Skip to main content

Bacillus amyloliquefaciens Ameliorates Dextran Sulfate Sodium-Induced Colitis by Improving Gut Microbial Dysbiosis in Mice Model

  • 2019-01-08
  • Frontiers in Microbiology 9
    • G. Cao
    • Kangli Wang
    • Zhanming Li
    • Fei Tao
    • Yinglei Xu
    • J. Lan
    • Guangyong Chen
    • Caimei Yang

Abstract

Several Bacillus strains exert beneficial effects on the maintenance of intestinal homeostasis and host health. However, whether Bacillus amyloliquefaciens (BA) can improve gut microbial dysbiosis and ameliorate colitis is unknown. Therefore, we conducted the present study to investigate the effects of BA administration on intestinal morphology, inflammatory response, and colonic microbial composition in a mouse model of dextran sulfate sodium (DSS)-induced colitis. Results showed that BA administration significantly ameliorated body weight loss, decreased disease activity index, and improved colonic tissue morphology in DSS-treated mice. In addition, levels of immunoglobulins, as well as pro-inflammatory cytokines, were decreased after BA administration. Importantly, colonic microbiota profiling indicated a significant (p < 0.05) difference in beta-diversity between BA-administrated and DSS-treated mice, according to weighted principal coordinate analysis (PCoA) results. The relative abundance of the Firmicutes genus was increased, whereas that of Bacteroidetes was decreased by BA administration. Furthermore, phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) analysis showed that the most significantly changed pathways between the four groups of mice were carbohydrate, lipid, and amino acid metabolism. In conclusion, our results showed that BA administration has beneficial effects on DSS-induced colitis, suggesting that this strategy might be useful for the treatment of dysbiosis during ulcerative colitis. Further, the changes in metabolism, especially amino acid metabolism, might contribute to the beneficial effects of BA on the amelioration of DSS-induced colitis.

Keywords: Bacillus amyloliquefaciens; colitis; inflammation; intestinal morphology; microbiota profiling.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus amyloliquefaciensImproved Body WeightBeneficial
Moderate
Bacillus amyloliquefaciensImproved Gut MorphologyBeneficial
Large
Bacillus amyloliquefaciensIncreased Abundance of FirmicutesBeneficial
Moderate
Bacillus amyloliquefaciensReduced Bacteroidetes AbundanceBeneficial
Moderate
Bacillus amyloliquefaciensReduced Disease Activity Index (DAI) LevelsBeneficial
Large
Bacillus amyloliquefaciensReduced Pro-inflammatory Cytokine LevelsBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.